|
Expanded Access to MGAWN1 in Subjects with Suspected West Nile Neuroinvasive Disease; Substantial Exposure, or Infection and a Compromised Immune System |
United States |
Zoonosis, Emerging Disease, and Drug Resistance, Pharmacology and Drug Treatment |
|
|
|
Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS) (Survey ID: Fx-R-001) |
United States |
Genetics, Neurology and Mental Health |
|
|